<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04206371</url>
  </required_header>
  <id_info>
    <org_study_id>2019/08</org_study_id>
    <nct_id>NCT04206371</nct_id>
  </id_info>
  <brief_title>Defibrillation Testing During Implantable Cardioverter Defibrillator (ICD) Replacement</brief_title>
  <acronym>T-DEF</acronym>
  <official_title>Longitudinal Follow-up of Patients With Defibrillator Threshold Testing During Implantable Cardioverter Defibrillator (ICD) Replacement</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>CMC Ambroise Paré</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>CMC Ambroise Paré</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will evaluate safety and clinical outcomes of a systematic defibrillation
      threshold testing in patient with indication for defibrillator replacement.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Implantable cardioverter defibrillators (ICD) are strongly recommended in patients with left
      ventricular systolic function ≤35% or selected patients with channelopathies and
      cardiomyopathies.

      Defibrillation threshold testing (DFT) defines the minimal energy required to successfully
      terminate a ventricular arrhythmia by an ICD. It remains the gold standard to evaluate the
      electrical integrity of the device. However inherent complications of this procedure have
      been registered, such as refractory ventricular fibrillation, and the need for this practice
      during implant and/or replacement of ICD has recently been questioned.

      If several studies have led to abandonment of the DFT during initial ICD implant, its
      interest during replacement is still controversial. Indeed, the leads essential for the
      device electrical integrity are older, more fragile, and the ICD replacement may damage it.

      Device replacement is indicated when battery reaches the point of Elective Replacement
      Interval (ERI).

      Patients over 18 years old with indication for replacement of defibrillator will be included.
      Patient's informations (comorbidities, medical history and events during hospitalization or
      follow-up) and device characteristics will be collected. Procedure will be realized under
      local or general anesthesia and prophylactic antibiotic will be administrated. Leads will be
      tested before and after the implantation of the new device. After connexion of the new
      implanted device to the leads a DFT will be performed. Protocol of DFT will be decided by the
      physician who will chose between induction of ventricular fibrillation or R-wave synchronized
      shock. Patients will be followed for 6 and 12 months from the date of defibrillator
      replacement.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 3, 2020</start_date>
  <completion_date type="Anticipated">February 3, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 3, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of defibrillator electrical integrity dysfunction during generator replacement.</measure>
    <time_frame>4 hours</time_frame>
    <description>Abnormal shock impedance value.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Rate of lead malfunction</measure>
    <time_frame>12 months</time_frame>
    <description>abnormal impedance value</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">330</enrollment>
  <condition>Implantable Cardioverter-Defibrillators</condition>
  <arm_group>
    <arm_group_label>Defibrillation testing during ICD replacment</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Defibrillator threshold testing</intervention_name>
    <description>Under general or local anesthesia. Induction of Ventricular Fibrillation or R-wave synchronized shock</description>
    <arm_group_label>Defibrillation testing during ICD replacment</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with an ICD (VR or DR) or CRT-D undergoing generator replacement.

          -  Consent for participation

          -  Affiliation to the French social security system

        Exclusion Criteria:

          -  Atrial Fibrillation without effective anti-coagulation treatments.

          -  Severe Aortic valve stenosis

          -  Stroke occurred in the previous month

          -  Hemodynamic instability contraindicating the high energy shock

          -  Contraindication for anesthesia

          -  Pregnant or breastfeeding women

          -  Communication difficulties or neuropsychiatric disorder

          -  Patients under protection of the adults (guardianship, curators or safeguard of
             justice)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Caroline Grimard, MD</last_name>
    <phone>(+33) 01 46 41 50 23</phone>
    <email>grimard@inparys.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Hôpital Trousseau</name>
      <address>
        <city>Chambray-lès-Tours</city>
        <state>Centre-Val De Loire</state>
        <zip>37170</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Institut Lorrain du Coeur et des Vaisseaux Louis Mathieu-CHU de Nancy-Hôpitaux de Brabois</name>
      <address>
        <city>Vandœuvre-lès-Nancy</city>
        <state>Grand Est</state>
        <zip>54500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>CMC Ambroise Paré</name>
      <address>
        <city>Neuilly-sur-Seine</city>
        <state>Ile-de-France</state>
        <zip>92200</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Caen</name>
      <address>
        <city>Caen</city>
        <state>Normandie</state>
        <zip>14000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>CHU de Toulouse-Hôpital Rangueil</name>
      <address>
        <city>Toulouse</city>
        <state>Occitanie</state>
        <zip>31400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location>
    <facility>
      <name>Hôpital Privé du Confluent</name>
      <address>
        <city>Nantes,</city>
        <state>Pays De La Loire</state>
        <zip>44277</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location>
    <facility>
      <name>Centre Hospitalier Henri Duffaut</name>
      <address>
        <city>Avignon</city>
        <state>Provence-Alpes-Côte d'Azur</state>
        <zip>84902</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>December 18, 2019</study_first_submitted>
  <study_first_submitted_qc>December 19, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">December 20, 2019</study_first_posted>
  <last_update_submitted>May 15, 2020</last_update_submitted>
  <last_update_submitted_qc>May 15, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Defibrillation threshold testing</keyword>
  <keyword>Defibrillation lead</keyword>
  <keyword>Defibrillator replacement</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

